Skip to main content

Drug Monitoring in Behavioral Health and During Times of Crisis

Today’s podcast will cover the role of clinical drug monitoring in Behavioral Health and during times of crisis. Important information shared will include:

  • Mental Health disorders, diagnosis and prevalence
  • The challenge of medication adherence in mental health treatment
  • The impact of crises on the treatment of patients with mental health conditions
  • The role of clinical drug monitoring

The episode features Dr Jeff Gudin, senior medical advisor and Dr Jack Kain, medical science liaison for the Quest Diagnostics Drug Monitoring and Toxicology division.

To listen to other podcasts in our Topics in Drug Testing series or learn more about Quest Diagnostics comprehensive drug testing offering, please visit There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

Date: Sunday, October 25, 2020

Author(s): Gudin, J, Kain, J